Speaker
Tariq Ahmad, MD, MPH
Director, Advanced Heart Failure Program
Yale School of Medicine and Yale New Haven Health
Topic
The Yale New Haven Health System as an Evidence Generation Ecosystem for Heart Failure
Keywords
Heart failure; Best practice alerts; Electronic health records; Risk prediction; Guideline-directed medical therapy; REVEAL-HF
Key Points
- The REVEAL-HF study is a pragmatic randomized controlled trial testing an electronic alert system that informs clinicians about the 1-year predicted mortality for their patients with heart failure using validated data from the EHR.
- It is important to use guideline-directed medical therapy for patients with heart failure. The hypothesis of the trial is that providing prognostic information for a patient with heart failure will lead to improved use of therapies and appropriate referral to subspecialties.
Discussion Themes
How did you get health system leadership and all of the clinicians, IT folks, and others to buy in to implementing your trial?
How can we make risk information valuable and actionable to healthcare providers?
Clinicians bring something to the table that an algorithm does not. It will be interesting to see how clinician behavior is affected by using the prediction models and interacting with the data.
Read more about the REVEAL-HF trial.
Tags
#pctGR, @Collaboratory1